Business Description
Adicet Bio Inc
NAICS : 541714
SIC : 2834
ISIN : US0070021086
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 7.63 | |||||
Equity-to-Asset | 0.82 | |||||
Debt-to-Equity | 0.12 | |||||
Debt-to-EBITDA | -0.15 | |||||
Piotroski F-Score | 1/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 15.2 | |||||
3-Year EPS without NRI Growth Rate | 17.1 | |||||
3-Year FCF Growth Rate | 26.8 | |||||
3-Year Book Growth Rate | -11 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 16.67 | |||||
9-Day RSI | 24.11 | |||||
14-Day RSI | 29.29 | |||||
6-1 Month Momentum % | 86.51 | |||||
12-1 Month Momentum % | -59.76 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 8.41 | |||||
Quick Ratio | 8.41 | |||||
Cash Ratio | 8.28 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -30 | |||||
Shareholder Yield % | -0.57 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -61.36 | |||||
ROA % | -52.69 | |||||
ROIC % | -193.99 | |||||
ROC (Joel Greenblatt) % | -299.98 | |||||
ROCE % | -56.68 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 0.4 | |||||
Price-to-Tangible-Book | 0.4 | |||||
EV-to-EBIT | 0.01 | |||||
EV-to-EBITDA | 0.01 | |||||
EV-to-Forward-EBITDA | -0.47 | |||||
EV-to-Forward-Revenue | 13.15 | |||||
EV-to-FCF | 0.01 | |||||
Price-to-Net-Current-Asset-Value | 0.55 | |||||
Price-to-Net-Cash | 0.56 | |||||
Earnings Yield (Greenblatt) % | No Debt | |||||
FCF Yield % | -75.15 |